Showing results (381-390 of 523) with videos related to
Sort By:
Pageof 53
Cancer Discovery|April 9, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET RearrangementsSeshiru Nakazawa, Federica Pecci, Igor Odintsov, et al.Cancers|October 3, 2020
Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)Andrea De Giglio, Laura Mezquita, Edouard Auclin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2017
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung CancerEnriqueta Felip, Fabrice Barlesi, Benjamin Besse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2022
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II TrialAlexander Drilon, Vivek Subbiah, Oliver Gautschi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2018
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective CohortClaire Merveilleux du Vignaux, Eric Dansin, Laurent Mhanna, et al.Lung Cancer (Amsterdam, Netherlands)|April 29, 2020
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancerSolange Peters, Alice T Shaw, Benjamin Besse, et al.Molecular Cancer|November 4, 2023
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) studyArnaud Bayle, Laila Belcaid, Lola-Jade Palmieri, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2017
Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers FranceNicolas Guibert, Fabrice Barlesi, Renaud Descourt, et al.European Journal of Cancer (Oxford, England : 1990)|June 18, 2025
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDSElisa Gobbini, Alexandra Langlais, Pascale Missy, et al.Biomarker Research|December 13, 2019
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1Isabelle Rouquette, Estelle Taranchon-Clermont, Julia Gilhodes, et al.Pageof 53